Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1

Completed · Phase 3

Conditions studied: Heroin Dependence, Substance-Related Disorders

In brief

The purpose of this study is the use of buprenorphine/naloxone in treatment of opioid dependence.

Key facts

Study ID

NCT00015171

Run by

National Institute on Drug Abuse (NIDA)

People needed

0

Starts

1996-04-01

Expected to finish

1997-06-01

Last updated by the study team

2017-01-16

Who can join

Age: 18 and older, up to 59. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• DSM-IV diagnosis of current opiate dependence males and non-pregnant, non-nursing female 18-59 yrs of age

You may not qualify if…

• Any significant medical condition AST or ALT levels greater than 3x's the upper limit of normal level Current Axis I diagnosis other than opiate, caffeine or nicotine dependence

Where it is running

• New York MDRU — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.